HETEROCYCLIC RING COMPOUND - TAKEDA PHARMACEUTICAL

Title:

HETEROCYCLIC RING COMPOUND

Document Type and Number:

WIPO Patent Application WO/2012/008549

Kind Code:

A1

Abstract:

Disclosed is a compound which has an activity of regulating the differentiation of a muscle cell or an adipocyte, is effective for the prevention or treatment of diseases including diabetes, obesity and dyslipidemia, and has excellent pharmacological efficacy. Specifically disclosed is a compound represented by formula (I) [wherein each symbol is as defined in the description] or a salt thereof.

More Like This:

JPH08512319	INDUSTRIAL APPLICABILITY
JPS5350178	PRODUCTION OF NN66 CHLORONICOTYNOYL HOMOCYSTEINE THIOLACTONE
JP7120549	Activator of TREK (TWIK-related K channel) channel

Inventors:

UJIKAWA OSAMU (JP)
TAKAMI KAZUAKI (JP)
TAKAKURA NOBUYUKI (JP)
SAKAI NOZOMU (JP)

Application Number:

PCT/JP2011/066153

Publication Date:

January 19, 2012

Filing Date:

July 14, 2011

Export Citation:

Click for automatic bibliography generation Help

Assignee:

TAKEDA PHARMACEUTICAL (JP)
UJIKAWA OSAMU (JP)
TAKAMI KAZUAKI (JP)
TAKAKURA NOBUYUKI (JP)
SAKAI NOZOMU (JP)

International Classes:

C07D213/56; A61K31/4418; A61K31/4439; A61K31/506; A61K31/5377; A61K31/675; A61P1/00; A61P1/04; A61P1/12; A61P1/14; A61P1/16; A61P3/00; A61P3/04; A61P3/06; A61P3/08; A61P3/10; A61P3/12; A61P7/00; A61P7/02; A61P7/10; A61P9/04; A61P9/10; A61P11/00; A61P13/10; A61P13/12; A61P15/00; A61P15/10; A61P17/00; A61P19/02; A61P19/06; A61P19/10; A61P21/04; A61P25/00; A61P25/02; A61P25/18; A61P25/24; A61P25/28; A61P27/02; A61P29/00; A61P31/04; A61P35/00; A61P35/02; A61P37/02; A61P43/00; C07D401/12; C07D413/12

Domestic Patent References:

WO2005069834A2	2005-08-04
WO2006090756A1	2006-08-31
WO2007030567A2	2007-03-15
WO2002028835A1	2002-04-11
WO2008021388A1	2008-02-21
WO2004041256A2	2004-05-21
WO2007008548A2	2007-01-18
WO2002022122A1	2002-03-21

Foreign References:

US20100113536A1

2010-05-06

Other References: